MarketCap
Facebook
X
TelegramQuarterly report 2024-Q3
added 11-07-2024
BIOLASE Market Cap 2011-2026 | BIOL
As of April 13, 2026 BIOLASE has a market cap of $ 166 K
Capitalization is the market value of a company whose shares are traded on the stock exchange. It is calculated by multiplying the market price of a share by the total number of the company's shares. Capitalization indicates volatility, risk, and growth potential. This metric is often used for a quick assessment of a company’s investment profile.[1]
Capitalization is an important indicator for investors and analysts, as it helps determine the size and significance of a company in the stock market. Companies with large capitalization are considered more stable and reliable, as they have more resources and financial power to grow and survive in the market.
This metric can be divided into several categories: small (from 300 million to 2 billion dollars), medium (from 2 to 10 billion dollars), and large (over 10 billion dollars). Companies with different levels of capitalization have their own characteristics and risks, so investors usually take this indicator into account when making investment decisions.
Capitalization can also change over time depending on the share price and the number of shares in circulation. Therefore, it is a dynamic indicator that requires constant monitoring and analysis to make well-informed investment decisions.
Annual Market Cap BIOLASE
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 192 K | 26.2 K | 546 K | 69.1 M | 14.2 M | 38.7 M | 31 M | 95.6 M | 58.3 M | 115 M | 85.7 M | 86.3 M | 99 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 115 M | 26.2 K | 53.4 M |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.
Market Cap of other stocks in the Medical devices industry
| Issuer | Market Cap | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Alphatec Holdings
ATEC
|
2.07 B | $ 10.89 | -0.11 % | $ 1.63 B |  USA |
 |
Cytosorbents Corporation
CTSO
|
34.8 M | $ 0.61 | - | $ 38 M | USA |
 |
AxoGen
AXGN
|
1.5 B | $ 31.98 | 0.06 % | $ 1.47 B | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
933 M | - | - | $ 1.77 B | USA |
 |
Acutus Medical
AFIB
|
5.24 M | - | -26.83 % | $ 2.62 M | USA |
 |
Align Technology
ALGN
|
13.9 B | $ 173.12 | -0.01 % | $ 13 B | USA |
 |
AdaptHealth Corp.
AHCO
|
1.2 B | $ 12.5 | 2.71 % | $ 1.69 B | USA |
 |
Allied Healthcare Products
AHPI
|
4.01 M | - | 3.58 % | $ 2.21 M | USA |
 |
Lianluo Smart Limited
LLIT
|
147 M | - | 24.59 % | $ 44.8 M |  China |
 |
Axonics Modulation Technologies
AXNX
|
2.82 B | - | - | $ 3.31 B | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
35 M | - | -5.86 % | $ 30.6 M | USA |
 |
Bio-Rad Laboratories
BIO
|
7.81 B | $ 282.0 | 1.03 % | $ 7.96 B | USA |
 |
BioSig Technologies
BSGM
|
7.3 M | - | 37.08 % | $ 85.7 M | USA |
 |
EDAP TMS S.A.
EDAP
|
139 M | $ 3.33 | 0.91 % | $ 125 M |  France |
 |
Conformis
CFMS
|
12.6 M | - | - | $ 16.4 M | USA |
 |
Bruker Corporation
BRKR
|
6.9 K | $ 37.77 | 0.48 % | $ 5.63 K | USA |
 |
Boston Scientific Corporation
BSX
|
113 B | $ 61.78 | 0.03 % | $ 91.5 B | USA |
 |
Apollo Endosurgery
APEN
|
403 M | - | - | $ 475 M | USA |
 |
Cardiovascular Systems
CSII
|
588 M | - | 0.15 % | $ 844 M | USA |
 |
ClearPoint Neuro
CLPT
|
316 M | $ 8.7 | 0.25 % | $ 246 M | USA |
 |
Dynatronics Corporation
DYNT
|
1.95 M | - | 14.99 % | $ 929 K | USA |
 |
Electromed
ELMD
|
175 M | $ 24.12 | - | $ 204 M | USA |
 |
CryoLife, Inc.
CRY
|
906 M | - | -4.14 % | $ 702 M | USA |
 |
Helius Medical Technologies
HSDT
|
3.54 M | $ 1.86 | -1.59 % | $ 1.13 M | USA |
 |
Avinger
AVGR
|
2.59 M | - | -20.74 % | $ 369 K | USA |
 |
Second Sight Medical Products
EYES
|
225 M | - | -0.97 % | $ 54.4 M | USA |
 |
CHF Solutions, Inc.
CHFS
|
1.05 M | - | 1.15 % | $ 34.5 M | USA |
 |
Inogen
INGN
|
160 M | $ 6.34 | 0.16 % | $ 169 M | USA |
 |
IRIDEX Corporation
IRIX
|
16.6 M | $ 0.99 | -0.99 % | $ 16.8 M | USA |
 |
Aziyo Biologics
AZYO
|
26.9 M | - | 1.37 % | $ 20.5 M | USA |
 |
Soliton, Inc.
SOLY
|
229 M | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
7.99 M | - | -1.98 % | $ 98.3 M | USA |
 |
GBS
GBS
|
2.48 M | - | -0.57 % | $ 7.12 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
339 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
Misonix, Inc.
MSON
|
185 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
677 M | - | - | $ 111 M |  Canada |
 |
OrthoPediatrics Corp.
KIDS
|
437 M | $ 15.89 | -0.5 % | $ 373 M | USA |
 |
LivaNova PLC
LIVN
|
3.81 B | $ 62.12 | -1.05 % | $ 3.39 B |  Britain |
 |
Globus Medical
GMED
|
12.5 B | $ 90.52 | 0.17 % | $ 12.2 B | USA |
 |
LENSAR
LNSR
|
71.3 M | $ 5.59 | -1.93 % | $ 66.8 M | USA |
 |
Butterfly Network
BFLY
|
766 M | $ 4.13 | 0.61 % | $ 874 M | USA |
 |
Intersect ENT, Inc.
XENT
|
735 M | - | - | $ 955 M | USA |
 |
Delcath Systems
DCTH
|
326 M | $ 10.4 | 3.59 % | $ 373 M | USA |
 |
Myomo
MYO
|
33.9 M | $ 0.69 | 0.51 % | $ 28.9 M | USA |
 |
Inspire Medical Systems
INSP
|
1.76 B | $ 53.9 | -0.19 % | $ 1.58 B | USA |
 |
CONMED Corporation
CNMD
|
1.32 B | $ 36.26 | -1.31 % | $ 1.13 B | USA |
 |
NanoVibronix
NAOV
|
920 K | - | - | $ 1.08 M | USA |
 |
Integer Holdings Corporation
ITGR
|
2.98 B | $ 84.8 | -0.4 % | $ 2.95 B | USA |
 |
FONAR Corporation
FONR
|
85.2 M | $ 18.65 | -0.16 % | $ 122 M | USA |